We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
AB Science and the University of Chicago (UC) have signed an exclusive licensing agreement to carry out research on Covid-19 prevention and treatment with the former’s oral drug, masitinib and other drugs.